AMPH
Price
$25.26
Change
-$0.64 (-2.47%)
Updated
Nov 19, 01:29 PM (EDT)
Capitalization
1.19B
105 days until earnings call
Intraday BUY SELL Signals
ELAN
Price
$21.24
Change
-$0.15 (-0.70%)
Updated
Nov 19, 03:15 PM (EDT)
Capitalization
10.63B
98 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AMPH vs ELAN

Header iconAMPH vs ELAN Comparison
Open Charts AMPH vs ELANBanner chart's image
Amphastar Pharmaceuticals
Price$25.26
Change-$0.64 (-2.47%)
Volume$4.75K
Capitalization1.19B
Elanco Animal Health
Price$21.24
Change-$0.15 (-0.70%)
Volume$7.13K
Capitalization10.63B
AMPH vs ELAN Comparison Chart in %
AMPH
Daily Signal:
Gain/Loss:
ELAN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AMPH vs. ELAN commentary
Nov 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPH is a Hold and ELAN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 19, 2025
Stock price -- (AMPH: $25.90 vs. ELAN: $21.39)
Brand notoriety: AMPH: Not notable vs. ELAN: Notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AMPH: 107% vs. ELAN: 69%
Market capitalization -- AMPH: $1.19B vs. ELAN: $10.63B
AMPH [@Pharmaceuticals: Generic] is valued at $1.19B. ELAN’s [@Pharmaceuticals: Generic] market capitalization is $10.63B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMPH’s FA Score shows that 0 FA rating(s) are green whileELAN’s FA Score has 1 green FA rating(s).

  • AMPH’s FA Score: 0 green, 5 red.
  • ELAN’s FA Score: 1 green, 4 red.
According to our system of comparison, ELAN is a better buy in the long-term than AMPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMPH’s TA Score shows that 6 TA indicator(s) are bullish while ELAN’s TA Score has 3 bullish TA indicator(s).

  • AMPH’s TA Score: 6 bullish, 5 bearish.
  • ELAN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AMPH is a better buy in the short-term than ELAN.

Price Growth

AMPH (@Pharmaceuticals: Generic) experienced а -4.64% price change this week, while ELAN (@Pharmaceuticals: Generic) price change was -6.43% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -3.85%. For the same industry, the average monthly price growth was -6.63%, and the average quarterly price growth was +28.06%.

Reported Earning Dates

AMPH is expected to report earnings on Mar 04, 2026.

ELAN is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-3.85% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELAN($10.6B) has a higher market cap than AMPH($1.19B). ELAN has higher P/E ratio than AMPH: ELAN (305.57) vs AMPH (11.46). ELAN YTD gains are higher at: 76.631 vs. AMPH (-30.245). ELAN has higher annual earnings (EBITDA): 1.45B vs. AMPH (248M). ELAN has more cash in the bank: 539M vs. AMPH (232M). AMPH has less debt than ELAN: AMPH (655M) vs ELAN (4.21B). ELAN has higher revenues than AMPH: ELAN (4.48B) vs AMPH (723M).
AMPHELANAMPH / ELAN
Capitalization1.19B10.6B11%
EBITDA248M1.45B17%
Gain YTD-30.24576.631-39%
P/E Ratio11.46305.574%
Revenue723M4.48B16%
Total Cash232M539M43%
Total Debt655M4.21B16%
FUNDAMENTALS RATINGS
AMPH vs ELAN: Fundamental Ratings
AMPH
ELAN
OUTLOOK RATING
1..100
7563
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
94
Overvalued
PROFIT vs RISK RATING
1..100
89100
SMR RATING
1..100
4776
PRICE GROWTH RATING
1..100
6040
P/E GROWTH RATING
1..100
702
SEASONALITY SCORE
1..100
5039

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMPH's Valuation (71) in the Pharmaceuticals Other industry is in the same range as ELAN (94) in the Agricultural Commodities Or Milling industry. This means that AMPH’s stock grew similarly to ELAN’s over the last 12 months.

AMPH's Profit vs Risk Rating (89) in the Pharmaceuticals Other industry is in the same range as ELAN (100) in the Agricultural Commodities Or Milling industry. This means that AMPH’s stock grew similarly to ELAN’s over the last 12 months.

AMPH's SMR Rating (47) in the Pharmaceuticals Other industry is in the same range as ELAN (76) in the Agricultural Commodities Or Milling industry. This means that AMPH’s stock grew similarly to ELAN’s over the last 12 months.

ELAN's Price Growth Rating (40) in the Agricultural Commodities Or Milling industry is in the same range as AMPH (60) in the Pharmaceuticals Other industry. This means that ELAN’s stock grew similarly to AMPH’s over the last 12 months.

ELAN's P/E Growth Rating (2) in the Agricultural Commodities Or Milling industry is significantly better than the same rating for AMPH (70) in the Pharmaceuticals Other industry. This means that ELAN’s stock grew significantly faster than AMPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMPHELAN
RSI
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
59%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
63%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 8 days ago
72%
Bullish Trend 9 days ago
64%
Declines
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 6 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
68%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
AMPH
Daily Signal:
Gain/Loss:
ELAN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GSG23.460.23
+0.99%
iShares S&P GSCI Commodity-Indexed Trust
OOSB14.080.02
+0.17%
One+One S&P 500 and Bitcoin ETF
BOBP25.89N/A
N/A
Core16 Best Of Breed Premier Index ETF
TSI4.89N/A
-0.10%
TCW Strategic Income Fund
SOYB23.73-0.07
-0.29%
Teucrium Soybean Fund

AMPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMPH has been loosely correlated with AMRX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if AMPH jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMPH
1D Price
Change %
AMPH100%
-0.46%
AMRX - AMPH
42%
Loosely correlated
-0.04%
COLL - AMPH
39%
Loosely correlated
-0.07%
ELAN - AMPH
37%
Loosely correlated
-0.14%
BHC - AMPH
35%
Loosely correlated
+0.82%
ZTS - AMPH
33%
Loosely correlated
-0.56%
More